Status:
UNKNOWN
Ramosetron OD Tablet and Postdischarge Nausea and Vomiting
Lead Sponsor:
Seoul National University Hospital
Conditions:
Day Surgery
Eligibility:
FEMALE
18-50 years
Phase:
PHASE4
Brief Summary
Postoperative nausea and vomiting after general anesthesia is one of the common anesthetic complications. If the patient is discharged from the hospital after surgery, proper treatment may be delayed ...
Eligibility Criteria
Inclusion
- Patients who undergo day-surgery under general anesthesia and are discharged on the day of surgery
Exclusion
- Pregnancy or breastfeeding
- Patients who are taking other serotonin receptor antagonists
- Patients who have galactose intolerance or Lapp lactase deficiency
- patients who have glucose-galactose malabsorption
Key Trial Info
Start Date :
May 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2022
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT04297293
Start Date
May 12 2020
End Date
February 28 2022
Last Update
December 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam-si, South Korea, 13620